Provided by Tiger Trade Technology Pte. Ltd.

Rocket Pharmaceuticals, Inc.

3.43
+0.08002.39%
Volume:1.29M
Turnover:4.40M
Market Cap:376.53M
PE:-20.18
High:3.48
Open:3.29
Low:3.29
Close:3.35
52wk High:5.45
52wk Low:2.53
Shares:109.77M
Float Shares:84.96M
Volume Ratio:1.21
T/O Rate:1.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1700
EPS(LYR):-2.0100
ROE:-4.77%
ROA:-28.42%
PB:1.02
PE(LYR):-1.71

Loading ...

Sep 21, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 20, 2022

Major Issues Report

8-K - Current report
Sep 20, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
Sep 20, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
Sep 20, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
Sep 09, 2022

Major Issues Report

8-K - Current report
Aug 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2022

Major Issues Report

8-K - Current report
Jun 15, 2022

Major Issues Report

8-K - Current report
May 06, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 11, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

Major Issues Report

8-K - Current report
Feb 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2021

Major Issues Report

8-K/A [Amend] - Current report